Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Dougherty & Co issued their Q3 2018 earnings estimates for Transcat in a research report issued on Monday. Dougherty & Co analyst R. Ryan forecasts that the scientific and technical instruments company will post earnings of $0.12 per share for the quarter. Dougherty & Co currently has a “Buy” rating and a $20.00 target price on the stock. Dougherty & Co also issued estimates for Transcat’s FY2018 earnings at $0.52 EPS.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/11/01/transcat-inc-trns-expected-to-post-q3-2018-earnings-of-0-12-per-share.html.

In other Transcat news, Director Paul D. Moore sold 4,000 shares of the business’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $13.00, for a total transaction of $52,000.00. Following the completion of the sale, the director now directly owns 57,698 shares in the company, valued at $750,074. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 8.80% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Northern Trust Corp grew its stake in Transcat by 9.5% during the second quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock worth $220,000 after buying an additional 1,570 shares during the period. QCI Asset Management Inc. NY boosted its stake in shares of Transcat by 10.0% in the second quarter. QCI Asset Management Inc. NY now owns 24,587 shares of the scientific and technical instruments company’s stock valued at $299,000 after purchasing an additional 2,226 shares during the period. WCM Investment Management CA boosted its stake in shares of Transcat by 0.7% in the second quarter. WCM Investment Management CA now owns 480,332 shares of the scientific and technical instruments company’s stock valued at $5,836,000 after purchasing an additional 3,545 shares during the period. Vanguard Group Inc. boosted its stake in shares of Transcat by 3.4% in the second quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock valued at $1,623,000 after purchasing an additional 4,450 shares during the period. Finally, Neuberger Berman Group LLC boosted its stake in shares of Transcat by 3.1% in the second quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock valued at $2,005,000 after purchasing an additional 4,900 shares during the period. Institutional investors own 56.22% of the company’s stock.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Receive News & Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related companies with MarketBeat.com's FREE daily email newsletter.